recombinant granulocyte-colony-stimulating factor
PURPOSE: We performed a phase I/II dose-escalation trial of cyclophosphamide,       mitoxantrone, and 5-fluorouracil (CNF) in combination with human recombinant       granulocyte-colony-stimulating factor (G-CSF, filgrastim) in patients with       advanced breast cancer.
PURPOSE: We performed a phase I/II dose-escalation trial of cyclophosphamide,       mitoxantrone, and 5-fluorouracil (CNF) in combination with human  @SUBJECT$  (G-CSF, filgrastim)  @PREDICAT$   @OBJECT$  with       advanced breast cancer.